Oliver Goedje

USPTO Granted Patents = 9 (Patent Applications = 11)

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 3.9

ph-index = 3

Forward Citations = 42(Granted Patents)

Location History:

Deining, DE (2010 - 2011)
Strasslach, DE (2013 - 2023)

Company Filing History:

Pulsion Medical Systems Ag

Pulsion Medical Systems Se

Years Active: 2010-2025

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12496384 - Formulations and methods for direct sodium removal in patients having heart failure and/or severe renal dysfunction (2025-12-16),

2. 11844890 - Formulations and methods for direct sodium removal in patients having heart failure and/or severe renal dysfunction (2023-12-19),

3. 11559618 - Formulations and methods for direct sodium removal in patients having severe renal dysfunction (2023-01-24),

4. 11464891 - Implantable pump for direct sodium removal therapy having on-board analyte sensor (2022-10-11),

5. 9949696 - Apparatus and methods for computing cardiac output of a living subject via applanation tonometry (2018-04-24),

6. 9655530 - Apparatus and methods for non-invasively measuring physiologic parameters of one or more subjects (2017-05-23),

7. 8521248 - Fiber-optic probe (2013-08-27),

8. 8016766 - Central venous catheter assembly for measuring physiological data for cardiac output determination and method of determining cardiac output (2011-09-13),

9. 7850617 - Patient monitoring apparatus and method for determining volume responsiveness of a monitored patient (2010-12-14),

Title: Innovations of Oliver Goedje in Direct Sodium Removal Therapies

Introduction

Oliver Goedje, an accomplished inventor based in Strasslach, Germany, has made significant contributions to medical science, particularly in the field of renal and cardiovascular health. With a portfolio of eight patents, Goedje's innovations are aimed at improving patient care for individuals suffering from severe renal dysfunction and heart failure.

Latest Patents

Goedje's latest patents focus on formulations and methods for direct sodium removal in patients facing heart failure and severe renal dysfunction. The first patent outlines a direct sodium removal ('DSR') infusate regimen designed to remove sodium and alleviate fluid overload in patients. This method involves instilling a DSR infusate with low or no sodium into a patient's peritoneal cavity. After a designated dwell period, sodium and excess fluid migrate to the cavity, allowing patients to subsequently undergo conventional dialysis to restore their sodium and fluid levels effectively. The similar approach is reiterated in a second patent, emphasizing the crucial role of DSR in providing relief for patients with significant health challenges.

Career Highlights

Throughout his career, Goedje has been associated with esteemed companies, including Sequana Medical NV and Pulsion Medical Systems AG. His work has been instrumental in driving innovative solutions that address critical health issues, particularly in the renal sector. His patents showcase his dedication to developing therapeutic options that enhance patient outcomes.

Collaborations

Goedje has collaborated with notable professionals in his field, including Matthias Bohn and Ian Crosbie. These partnerships have likely enriched his innovative pursuits, combining their expertise to refine and advance medical technologies that could benefit countless patients.

Conclusion

Oliver Goedje's contributions to medical innovation, particularly concerning direct sodium removal therapies, represent a significant leap forward in treating severe renal dysfunction and heart failure. His patented methodologies not only highlight his inventive spirit but also underscore the critical importance of ongoing research and development in medical science. As his career progresses, it will be exciting to see how his work continues to evolve and impact the healthcare landscape.

This text is generated by artificial intelligence and may not be accurate.